Skip to content
Home/Companies/Healthcare/Synthon
Synthon

Synthon

Healthcare·Netherlands·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns Synthon?

Synthon was owned by BC Partners through BC European Capital X (2018 vintage) from 2019 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

BC Partners
Investor
BC Partners
BC European Capital X · 2018 · Buyout

Key facts

HQNetherlands
SectorHealthcare
Websitewww.synthon.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from BC European Capital X

Other portfolio companies in the same fund.

Keesing Media Group
Keesing Media Group
Active
ConsumerNetherlands· 2021
Ponroy Santé (Havea Group)
Active
HealthcareFrance· 2021
Tentamus
Active
Business ServicesGermany· 2021
IMA
IMA
Exited 2024
IndustrialsItaly· 2020
to
Keesing
Keesing
Active
GamingNetherlands· 2020
Women's Care Enterprises
Women's Care Enterprises
Active
HealthcareUS· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Synthon

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Synthon?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Synthon.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue